Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age

QJM: An International Journal of Medicine

Volumn 95, Issue 11, 2002, Pages 733-740

  Daly, S ^a   Mills, J L ^b   Molloy, A M ^c   Conley, M ^b   McPartlin, J ^c   Lee, Y J ^b   Young, P B ^d   Kirke, P N ^e   Weir, D G ^c   Scott, J M ^c  

^a Pathology Research Laboratory   (Ireland)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^e HEALTH RESEARCH BOARD   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PLACEBO;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NEUROPROTECTION; PREECLAMPSIA; PREMENOPAUSE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION; VITAMIN SUPPLEMENTATION;

EID: 0036843118     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/95.11.733     Document Type: Article

References (23)

1. Motulsky AG. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996; 58:17-20.
2. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and the risk of stroke in middle aged British men. Lancet 1995; 346:1395-8.
3. Boushey CJ, Beresford SS, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 275:1049-57.
4. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-55.
5. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185:781-5.
6. Ward M, McNulty J, McPartlin J, Strain JJ, Weir DG, Scott JM. Plasma homocysteine, a risk factor for cardiovascular disease, can be effectively lowered by physiological amounts of folic acid. Q J Med 1997; 90:519-24.
7. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. Br Med J 1998; 316:894-8.
8. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001; 161:695-700.
9. Rydlewicz A, Simpson JA, Taylor RJ, Bond CM, Golden MH. The effect of folic acid supplementation on plasma homocysteine in an elderly population. Q J Med 2002; 95:27-35.
10. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001; 345:1593-1600.
11. Schorah S, Devitt H, Lucock M, Dowell AC. The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study. Eur J Clin Nutr 1998; 52:407-11.
12. Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WE, Phillipson BE, et al. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998; 338:1009-15.
13. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 2000; 71:962-8.
14. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, et al. Minimum effective dose of folic acid for food fortification to prevent neural tube defects. Lancet 1997; 350:1666-9.
15. Chanarin I. The Megaloblastic Anaemias. 3rd edn. Oxford, Blackwell Scientific Publications, 1990.
16. Molloy AM, Scott JM. Microbiological assay for serum, plasma and red cell folate using cryopreserved microtitre plate method. Methods Enzymol 1997; 281:43-53.
17. Leino A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx analyzer. Clin Chem 1999; 45:569-71.
18. Kelleher BP, O'Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991; 44:592-5.
19. Young PB, Blanchflower WJ, Hewitt SA, Price J, Kennedy DG. Sensitive gas chromatographic-high resolution mass spectrometric method for the determination of methylmalonic acid in bovine plasma. Analyst 1995; 120:2199-201.
20. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-8.
21. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999; 340:1449-54.
22. Jonckheere AR. A distribution free k-sample test against ordered alternatives. Biometrika 1954; 41:133-45.
23. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA 1995; 274:1698-702.